TrialAnnals of the rheumatic diseases2017

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.

Won Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.